Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 25,582 $ 43,475
Trade receivables, net 15,404 15,524
Other receivables 14,897 17,502
Prepayments and contract assets 18,404 18,349
Assets held for sale 108,797 125,275
Total current assets 183,084 220,125
Property, plant and equipment, net 12,039 12,658
Operating lease right-of-use assets 12,870 13,327
Total assets 207,993 246,110
Current liabilities    
Trade payables 5,893 9,600
Other payables 4,046 4,839
Accruals and other liabilities 40,000 30,029
Due to related parties 4,791 4,791
Claims payable 9,280 8,475
Contract liabilities 19,094 18,710
Lease liabilities 5,023 5,102
Liabilities held for sale 70,351 74,717
Premium deficiency reserve 13,103 6,124
Total current liabilities 171,581 162,387
Loans and borrowings, net of current position 295,449 278,028
Contract liabilities, net of current position 42,790 46,160
Lease liabilities, net of current portion 12,983 14,056
Warrant liability 0 711
Earnout liability 252 667
Total liabilities 523,055 502,009
SHAREHOLDERS' EQUITY    
Additional paid-in capital 581,215 576,585
Accumulated deficit (900,001) (836,772)
Accumulated other comprehensive income 3,707 4,272
Total shareholders' equity (315,062) (255,899)
Total liabilities and shareholders' equity 207,993 246,110
Class A ordinary shares    
SHAREHOLDERS' EQUITY    
Ordinary shares 17 16
Class B ordinary shares    
SHAREHOLDERS' EQUITY    
Ordinary shares $ 0 $ 0